We build upon these data by directly confirming that the UPR is activated in IPF AECs and that circulating levels of cCK-18, a cleavage product of cytokeratin 18 formed during the UPR, is elevated in IPF patients. This evidence concerns the gene KRT18 and idiopathic pulmonary fibrosis.